Abstract Background The efficacy and safety of direct oral anticoagulants (DOACs) for patients with thrombotic antiphospholipid syndrome remain controversial. Objectives The authors performed a sys...
Abstract Background The efficacy and safety of direct oral anticoagulants (DOACs) for patients with thrombotic antiphospholipid syndrome remain controversial. Objectives The authors performed a sys...
One of the few uses left for warfarin